TrialKit AI

TrialKit AI is an integrated artificial intelligence engine within the TrialKit platform, designed to revolutionize clinical trial data analysis and reporting. It enables querying, analyzing, and interpreting complex data in seconds using natural language processing and automated intelligence. Unlike generic solutions, TrialKit AI is specifically crafted for life sciences and supports all phases of clinical research.

The platform offers:

• Natural language querying capabilities
• Advanced biostatistical analysis with instant p-values and confidence intervals
• Real-time updating visual dashboards
• Support for multi-trial, multi-source analytics
• Compliance with HIPAA, FDA 21 CFR Part 11, and GDPR

TrialKit AI, internally known as Floyd, utilizes over 50 built-in reports and data inputs, including native EDC and real-world data sources like wearables and imaging. It allows users to monitor adverse events, enrollment trends, and site performance with simple queries, providing instant visual outputs and statistically valid results.

Vision AI: Intelligent Medical Image Recognition

The Vision AI module enhances TrialKit AI by analyzing high-resolution DICOM images to detect anomalies such as tumors or fractures. It identifies complex data signatures, highlights anomalies invisible to radiologists, enlarges areas of interest, and predicts disease progression. This is particularly beneficial in oncology and radiology-driven trials, adding a new dimension to pre-screening and image-based data validation.

Virtual Trials: From 5 Years to 5 Minutes

TrialKit AI supports virtual trials by simulating disease progression over time, compressing multi-year study timelines into minutes. It projects treatment outcomes using modeled population data, enables rapid iteration of study designs, and supports FDA-guided initiatives for AI in preclinical research. By integrating data from millions of participants and thousands of studies, it helps optimize trial outcomes before patient enrollment.

Real-world use cases include combining EDC, ePRO/eCOA, and wearable data for real-time safety tracking, automatically flagging sites with protocol deviations, predicting trial delays and enrollment gaps, detecting image-based anomalies for early intervention, and simulating outcomes for different populations using virtual participants.

TrialKit AI streamlines data management with its intuitive interface and natural language processing capabilities, allowing researchers to interact effortlessly and adopt the system rapidly. It automates complex data processing tasks, ensuring accuracy and minimizing human error. Advanced visualization tools transform data into interpretable formats, facilitating quick and informed decision-making.

The platform offers efficiency gains and cost savings by automating tasks traditionally handled by data managers and statisticians, reducing labor costs, and shortening study timelines. TrialKit AI ensures trust and transparency in AI-driven results through its “thought pathway” feature, allowing users to verify and trust the conclusions.

TrialKit AI adheres to FDA, GDPR, and HIPAA guidelines, ensuring secure data handling and compliance. It integrates seamlessly with existing clinical trial data sources, automating patient monitoring, safety tracking, and anomaly detection in real-time.